Wells Fargo Upgrades C4 Therapeutics (CCCC) to Overweight
Tweet Send to a Friend
Wells Fargo analyst Derek Archila upgraded C4 Therapeutics (NASDAQ: CCCC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
